Показано 0 из 0
Дата |
---|
11.04.2024 |
10.04.2024 |
09.04.2024 |
08.04.2024 |
05.04.2024 |
04.04.2024 |
03.04.2024 |
02.04.2024 |
01.04.2024 |
28.03.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.5656
|
0.599
|
0.7838
|
0.6116
|
0.85
|
0.661
|
|
|
291 247.99
|
1 447.00
|
0.851
|
0.88
|
1.04
|
0.81
|
1.04
|
0.8797
|
|
|
307 622.68
|
1 300.00
|
1.03
|
1.05
|
1.09
|
0.98
|
1.11
|
1.02
|
|
|
1 689 241.14
|
6 966.00
|
1.16
|
1.25
|
1.23
|
1.1209
|
1.37
|
1.20
|
|
|
329 162.29
|
1 068.00
|
1.38
|
1.42
|
1.62
|
1.31
|
1.6214
|
1.35
|
|
|
516 553.98
|
1 551.00
|
1.60
|
1.71
|
1.80
|
1.68
|
2.01
|
1.68
|
|
|
946 128.40
|
2 132.00
|
1.87
|
2.02
|
1.98
|
1.88
|
2.40
|
1.99
|
|
|
1 769 995.81
|
4 479.00
|
2.22
|
2.25
|
2.21
|
1.65
|
4.1301
|
2.50
|
|
|
10 712 513.31
|
20 848.00
|
4.00
|
6.02
|
13.48
|
13.305
|
13.48
|
13.47
|
|
|
128 219.26
|
259.00
|
13.98
|
15.00
|
12.39
|
11.82
|
13.315
|
13.211
|
|
|
59 122.71
|
90.00
|
Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company. The Company is engaged in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system.